|
| 37943168 | The Breast Microbiome in Breast Cancer Risk and Progression: A Narrative Review. | Cancer Epidemiol Biomarkers Prev | 2024 |
| 38079601 | International Pooled Analysis of Leisure-Time Physical Activity and Premenopausal Breast Cancer in Women From 19 Cohorts. | J Clin Oncol | 2024 |
| 38013398 | Circulating levels of biomarkers and risk of ductal carcinoma in situ of the breast in the UK Biobank study. | Int J Cancer | 2024 |
| 37955559 | Metabolic Syndrome and the Risk of Ductal Carcinoma In Situ of the Breast in the UK Biobank. | Cancer Epidemiol Biomarkers Prev | 2024 |
| 36151863 | Circulating immune markers and risks of non-Hodgkin lymphoma subtypes: A pooled analysis. | Int J Cancer | 2023 |
| 37491663 | Correction to: Healthy lifestyle index and risk of pancreatic cancer in the Women's Health Initiative. | Cancer Causes Control | 2023 |
| 37527476 | Menopausal hormone therapy and change in physical activity in the Women's Health Initiative hormone therapy clinical trials. | Menopause | 2023 |
| 37886553 | Heterogeneous genetic architectures and evolutionary genomics of prostate cancer in Sub-Saharan Africa. | Res Sq | 2023 |
| 37579307 | Inflammatory Bowel Disease and Risk of Global Cardiovascular Diseases and Type 2 Diabetes. | Inflamm Bowel Dis | 2023 |
| 37879292 | The association of the healthy eating index with risk of colorectal cancers (overall and by subsite) among Canadians. | Cancer Epidemiol | 2023 |
| 37645769 | Alcohol intake and endogenous sex hormones in women: meta-analysis of cohort studies and Mendelian randomization. | Res Sq | 2023 |
| 37532890 | Correction: Associations of coffee/caffeine consumption with postmenopausal breast cancer risk and their interactions with postmenopausal hormone use. | Eur J Nutr | 2023 |
| 35524005 | Hypothesized Explanations for the Observed Lung Cancer Survival Benefit Among Hispanics/Latinos in the United States. | J Racial Ethn Health Disparities | 2023 |
| 37425211 | Endogenous sex steroid hormones and risk of liver cancer among US men: Results from the Liver Cancer Pooling Project. | JHEP Rep | 2023 |
| 37306150 | Healthy Lifestyle Index and Risk of Cardiovascular Disease Among Postmenopausal Women With Normal Body Mass Index. | J Am Heart Assoc | 2023 |
| 37029916 | Associations of life course obesity with endometrial cancer in the Epidemiology of Endometrial Cancer Consortium (E2C2). | Int J Epidemiol | 2023 |
| 37463321 | Association Between the Healthy Lifestyle Index and Risk of Multimorbidity in the Women's Health Initiative. | J Gerontol A Biol Sci Med Sci | 2023 |
| 36444502 | Diabetes, metformin use and risk of non-Hodgkin's lymphoma in postmenopausal women: A prospective cohort analysis in the Women's Health Initiative. | Int J Cancer | 2023 |
| 36404465 | Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program. | Ann Epidemiol | 2023 |
| 35968582 | Proton Pump Inhibitor Use and Obesity-Associated Cancer in the Women's Health Initiative. | Nutr Cancer | 2023 |
| 34074183 | The associations of CD4 count, CD4/CD8 ratio, and HIV viral load with survival from non-small cell lung cancer in persons living with HIV. | AIDS Care | 2022 |
| 35583696 | Associations of coffee/caffeine consumption with postmenopausal breast cancer risk and their interactions with postmenopausal hormone use. | Eur J Nutr | 2022 |
| 35437601 | Association of Prediagnostic Serum Levels of Vitamin D with Risk of Ductal Carcinoma In Situ of the Breast in the UK Biobank Cohort Study. | Cancer Epidemiol Biomarkers Prev | 2022 |
| 35578919 | Racial disparity in distant recurrence-free survival in patients with localized breast cancer: A pooled analysis of National Surgical Adjuvant Breast and Bowel Project trials. | Cancer | 2022 |
| 35429338 | Healthy lifestyle index and the risk of ductal carcinoma in situ of the breast in the Women's Health Initiative. | Int J Cancer | 2022 |
| 35565297 | Combining TMEM Doorway Score and Mena<sup>Calc</sup> Score Improves the Prediction of Distant Recurrence Risk in HR+/HER2- Breast Cancer Patients. | Cancers (Basel) | 2022 |
| 36712480 | Prospective associations of hemoglobin A<sub>1c</sub> and c-peptide with risk of diabetes-related cancers in the Cancer Prevention Study-II Nutrition Cohort. | Cancer Res Commun | 2022 |
| 36104689 | Association of sleep duration and insomnia with metabolic syndrome and its components in the Women's Health Initiative. | BMC Endocr Disord | 2022 |
| 36100952 | Testing the generalizability of ancestry-specific polygenic risk scores to predict prostate cancer in sub-Saharan Africa. | Genome Biol | 2022 |
| 35102370 | Sustained Weight Loss, Weight Cycling, and Weight Gain During Adulthood and Pancreatic Cancer Incidence in the Women's Health Initiative. | Am J Epidemiol | 2022 |
| 35012972 | The Association of Predicted Resting Energy Expenditure with Risk of Breast Cancer among Postmenopausal Women in the Women's Health Initiative Cohort. | Cancer Prev Res (Phila) | 2022 |
| 34999850 | Physical activity and risk of benign proliferative epithelial disorders of the breast, in the Women's Health Initiative. | Int J Epidemiol | 2022 |
| 34933955 | Association of a Healthy Lifestyle Index with Risk of Breast Cancer among Women with Normal Body Mass Index in the UK Biobank. | Cancer Epidemiol Biomarkers Prev | 2022 |
| 35235084 | Healthy lifestyle index and risk of pancreatic cancer in the Women's Health Initiative. | Cancer Causes Control | 2022 |
| 35048536 | Adiposity and breast, endometrial, and colorectal cancer risk in postmenopausal women: Quantification of the mediating effects of leptin, C-reactive protein, fasting insulin, and estradiol. | Cancer Med | 2022 |
| 34732526 | Body Fat Distribution, Cardiometabolic Traits, and Risk of Major Lower-Extremity Arterial Disease in Postmenopausal Women. | Diabetes Care | 2022 |
| 34783926 | Overall and central obesity and prostate cancer risk in African men. | Cancer Causes Control | 2022 |
| 34652432 | Cohort Profile: The Ovarian Cancer Cohort Consortium (OC3). | Int J Epidemiol | 2022 |
| 34677741 | Racial and ethnic differences in all-cause mortality among Hispanics diagnosed with follicular lymphoma and chronic lymphocytic leukemia in the Bronx, NY. | Cancer Causes Control | 2022 |
| 33010161 | Recommended Definitions of Aggressive Prostate Cancer for Etiologic Epidemiologic Research. | J Natl Cancer Inst | 2021 |
| 33827986 | Dietary Patterns of Insulinemia, Inflammation and Glycemia, and Pancreatic Cancer Risk: Findings from the Women's Health Initiative. | Cancer Epidemiol Biomarkers Prev | 2021 |
| 33879453 | Circulating Levels of Testosterone, Sex Hormone Binding Globulin and Colorectal Cancer Risk: Observational and Mendelian Randomization Analyses. | Cancer Epidemiol Biomarkers Prev | 2021 |
| 33516237 | Infiltrating immune cells in benign breast disease and risk of subsequent invasive breast cancer. | Breast Cancer Res | 2021 |
| 33622671 | Sex Hormones, Insulin, and Insulin-like Growth Factors in Recurrence of High-Stage Endometrial Cancer. | Cancer Epidemiol Biomarkers Prev | 2021 |
| 33736682 | Risk factors for breast cancer development by tumor characteristics among women with benign breast disease. | Breast Cancer Res | 2021 |
| 33567105 | The association of prediagnostic circulating levels of cardiometabolic markers, testosterone and sex hormone-binding globulin with risk of breast cancer among normal weight postmenopausal women in the UK Biobank. | Int J Cancer | 2021 |
| 33563604 | Cancer Risk in Normal Weight Individuals with Metabolic Obesity: A Narrative Review. | Cancer Prev Res (Phila) | 2021 |
| 33723399 | The association of body fat composition with risk of breast, endometrial, ovarian and colorectal cancers among normal weight participants in the UK Biobank. | Br J Cancer | 2021 |
| 34948771 | Characterizing Trends in Lung Cancer Mortality Attributable to Airborne Environmental Carcinogens. | Int J Environ Res Public Health | 2021 |
| 34702732 | Molecular markers of risk of subsequent invasive breast cancer in women with ductal carcinoma in situ: protocol for a population-based cohort study. | BMJ Open | 2021 |